FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991361605> ?p ?o ?g. }

• W1991361605 endingPage "6334" @default.
• W1991361605 startingPage "6327" @default.
• W1991361605 abstract "MicroRNA-452 (miRNA-452) was overexpressed in docetaxel-resistant human breast cancer MCF-7 cells (MCF-7/DOC). However, its role in modulating the sensitivity of breast cancer cells to docetaxel (DOC) remains unclear. The aim of this study is to investigate the role of miRNA-452 in the sensitivity of breast cancer cells to DOC.Real-time quantitative PCR (RT-qPCR) were used to identify the differential expression of miRNA-452 between MCF-7/DOC and MCF-7 cells. MiRNA-452 mimic was transfected into MCF-7 cells and miRNA-452 inhibitor was transfected into MCF-7/DOC cells. The role of miRNA-452 in these transfected cells was evaluated using RT-qPCR, MTT assay, and flow cytometry assay. The relationship of miRNA-452 and its predictive target gene anaphase-promoting complex 4 (APC4) was analyzed by RT-qPCR and Western blot.MiRNA-452 showed significantly higher expression (78.9-folds) in MCF-7/DOC cells compared to parental MCF-7 cells. The expression of miRNA-452 in the mimic transfected MCF-7 cells was upregulated 212.2-folds (P < 0.05) compared to its negative control (NC), and the half maximal inhibitory concentration (IC50) value of DOC (1.98 ± 0.15 μM) was significantly higher than that in its NC (0.85 ± 0.08 μM, P < 0.05) or blank control (1.01 ± 0.19 μM, P < 0.05). Furthermore, its apoptotic rate (6.3 ± 1.3 %) was distinctly decreased compared with that in its NC (23.8 ± 6.6 %, P < 0.05) or blank control (18.6 ± 4.7 %, P < 0.05). In contrast, the expression of miRNA-452 in the inhibitor-transfected MCF-7/DOC cells was downregulated 0.58-fold (P < 0.05) compared to its NC, the IC50 value of DOC (44.5 ± 3.2 μM) was significantly lower than that in its NC (107.3 ± 6.63 μM, P < 0.05) or blank control (102.22 ± 11.34 μM, P < 0.05), and the apoptotic rate (45.5 ± 10.8 %) was distinctly increased compared with its NC (9.9 ± 2.2 %, P < 0.05) and blank control (9.4 ± 2.5 %, P < 0.05). Further, there was an inverse association between miRNA-452 and APC4 expression in breast cancer cells in vitro.Dysregulation of miRNA-452 involved in the DOC resistance formation of breast cancer cells may be, in part, via targeting APC4." @default.
• W1991361605 created "2016-06-24" @default.
• W1991361605 creator A5008910996 @default.
• W1991361605 creator A5009624424 @default.
• W1991361605 creator A5025133946 @default.
• W1991361605 creator A5027118370 @default.
• W1991361605 creator A5032349293 @default.
• W1991361605 creator A5033259787 @default.
• W1991361605 creator A5034188544 @default.
• W1991361605 creator A5053260505 @default.
• W1991361605 creator A5055730436 @default.
• W1991361605 date "2014-03-20" @default.
• W1991361605 modified "2023-10-16" @default.
• W1991361605 title "MicroRNA-452 contributes to the docetaxel resistance of breast cancer cells" @default.
• W1991361605 cites W109554055 @default.
• W1991361605 cites W1873609678 @default.
• W1991361605 cites W1982717012 @default.
• W1991361605 cites W1987903396 @default.
• W1991361605 cites W1990965835 @default.
• W1991361605 cites W1991942035 @default.
• W1991361605 cites W1995630283 @default.
• W1991361605 cites W1998170462 @default.
• W1991361605 cites W2007118283 @default.
• W1991361605 cites W2011694166 @default.
• W1991361605 cites W2040066648 @default.
• W1991361605 cites W2093855538 @default.
• W1991361605 cites W2105728472 @default.
• W1991361605 cites W2107277218 @default.
• W1991361605 cites W2113521816 @default.
• W1991361605 cites W2116535376 @default.
• W1991361605 cites W2129731003 @default.
• W1991361605 cites W2145387574 @default.
• W1991361605 cites W2149178140 @default.
• W1991361605 cites W2155380705 @default.
• W1991361605 cites W2161817637 @default.
• W1991361605 cites W2164758046 @default.
• W1991361605 doi "https://doi.org/10.1007/s13277-014-1834-z" @default.
• W1991361605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24648265" @default.
• W1991361605 hasPublicationYear "2014" @default.
• W1991361605 type Work @default.
• W1991361605 sameAs 1991361605 @default.
• W1991361605 citedByCount "23" @default.
• W1991361605 countsByYear W19913616052015 @default.
• W1991361605 countsByYear W19913616052016 @default.
• W1991361605 countsByYear W19913616052017 @default.
• W1991361605 countsByYear W19913616052018 @default.
• W1991361605 countsByYear W19913616052019 @default.
• W1991361605 countsByYear W19913616052020 @default.
• W1991361605 countsByYear W19913616052021 @default.
• W1991361605 countsByYear W19913616052022 @default.
• W1991361605 countsByYear W19913616052023 @default.
• W1991361605 crossrefType "journal-article" @default.
• W1991361605 hasAuthorship W1991361605A5008910996 @default.
• W1991361605 hasAuthorship W1991361605A5009624424 @default.
• W1991361605 hasAuthorship W1991361605A5025133946 @default.
• W1991361605 hasAuthorship W1991361605A5027118370 @default.
• W1991361605 hasAuthorship W1991361605A5032349293 @default.
• W1991361605 hasAuthorship W1991361605A5033259787 @default.
• W1991361605 hasAuthorship W1991361605A5034188544 @default.
• W1991361605 hasAuthorship W1991361605A5053260505 @default.
• W1991361605 hasAuthorship W1991361605A5055730436 @default.
• W1991361605 hasConcept C104317684 @default.
• W1991361605 hasConcept C109541995 @default.
• W1991361605 hasConcept C121608353 @default.
• W1991361605 hasConcept C126322002 @default.
• W1991361605 hasConcept C145059251 @default.
• W1991361605 hasConcept C153911025 @default.
• W1991361605 hasConcept C185592680 @default.
• W1991361605 hasConcept C190283241 @default.
• W1991361605 hasConcept C2781190966 @default.
• W1991361605 hasConcept C2994423619 @default.
• W1991361605 hasConcept C502942594 @default.
• W1991361605 hasConcept C530470458 @default.
• W1991361605 hasConcept C54009773 @default.
• W1991361605 hasConcept C54355233 @default.
• W1991361605 hasConcept C553184892 @default.
• W1991361605 hasConcept C55493867 @default.
• W1991361605 hasConcept C71924100 @default.
• W1991361605 hasConcept C81885089 @default.
• W1991361605 hasConcept C86803240 @default.
• W1991361605 hasConcept C96232424 @default.
• W1991361605 hasConceptScore W1991361605C104317684 @default.
• W1991361605 hasConceptScore W1991361605C109541995 @default.
• W1991361605 hasConceptScore W1991361605C121608353 @default.
• W1991361605 hasConceptScore W1991361605C126322002 @default.
• W1991361605 hasConceptScore W1991361605C145059251 @default.
• W1991361605 hasConceptScore W1991361605C153911025 @default.
• W1991361605 hasConceptScore W1991361605C185592680 @default.
• W1991361605 hasConceptScore W1991361605C190283241 @default.
• W1991361605 hasConceptScore W1991361605C2781190966 @default.
• W1991361605 hasConceptScore W1991361605C2994423619 @default.
• W1991361605 hasConceptScore W1991361605C502942594 @default.
• W1991361605 hasConceptScore W1991361605C530470458 @default.
• W1991361605 hasConceptScore W1991361605C54009773 @default.
• W1991361605 hasConceptScore W1991361605C54355233 @default.
• W1991361605 hasConceptScore W1991361605C553184892 @default.
• W1991361605 hasConceptScore W1991361605C55493867 @default.
• W1991361605 hasConceptScore W1991361605C71924100 @default.

• next